Feedback of Antibiotic Prescribing in Primary Care (FAPPC) trial: results of a real-world cluster randomized controlled trial in Scotland, UK.
Journal
The Journal of antimicrobial chemotherapy
ISSN: 1460-2091
Titre abrégé: J Antimicrob Chemother
Pays: England
ID NLM: 7513617
Informations de publication
Date de publication:
28 11 2022
28 11 2022
Historique:
received:
17
02
2022
accepted:
30
08
2022
pubmed:
30
9
2022
medline:
1
12
2022
entrez:
29
9
2022
Statut:
ppublish
Résumé
To evaluate the effect of general practice-level prescribing feedback on antibiotic prescribing in a real-world pragmatic cluster randomized controlled trial. Three hundred and forty general practices in four territorial Health Boards in NHS Scotland were randomized in Quarter 1, 2016 to receive four quarterly antibiotic-prescribing feedback reports or not, from Quarter 2, 2016 to Quarter 1, 2017. Reports included different clinical topics, benchmarking against national and health board rates, and behavioural messaging with improvement actions. The primary outcome was total antibiotic prescribing rate. There were 16 secondary prescribing outcomes and 5 hospital admission outcomes (potential adverse effects of reduced prescribing). The main evaluation timepoint was 1 year after the final report (Quarter 1, 2018), with an additional evaluation in the quarter after the final report (Quarter 2, 2017). Routine administrative NHS data were used to generate the feedback reports and analyse the effects. Total antibiotic prescribing rates were lower at the main evaluation timepoint in both intervention (1.83 versus baseline 1.93 prescriptions/1000 patients/day) and control (1.90 versus baseline 1.98) practices, with no evidence of intervention effect [adjusted rate ratio (ARR) 0.98 (95% CI 0.94-1.02; P = 0.35)]. At the additional timepoint, adjusted total antibiotic prescribing rates were 1.67 and 1.73 prescriptions/1000 patients/day, with evidence of a small intervention effect, ARR 0.99 (0.98-1.00; P = 0.03). This well-designed, practice-level antibiotic-prescribing feedback had limited evidence of additional effects in the context of decreasing antibiotic prescribing and an established national stewardship programme.
Identifiants
pubmed: 36172861
pii: 6730390
doi: 10.1093/jac/dkac317
pmc: PMC9704438
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3291-3300Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.
Références
J Antimicrob Chemother. 2015 Feb;70(2):602-8
pubmed: 25326088
Implement Sci. 2010 Jul 20;5:57
pubmed: 20646275
CMAJ. 1999 Aug 24;161(4):388-92
pubmed: 10478162
Lancet. 2012 Apr 7;379(9823):1310-9
pubmed: 22357106
Drug Ther Bull. 2021 Feb;59(2):24-28
pubmed: 33509906
N Engl J Med. 2016 Mar 17;374(11):1053-64
pubmed: 26981935
Fam Med. 2000 Jan;32(1):22-9
pubmed: 10645510
Qual Health Care. 2000 Sep;9(3):159-65
pubmed: 10980076
BMJ. 1999 Feb 20;318(7182):507-11
pubmed: 10024260
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
CMAJ. 2016 Feb 2;188(2):108-115
pubmed: 26573754
Br J Clin Pharmacol. 2020 Feb;86(2):250-257
pubmed: 31758595
Scand J Prim Health Care. 2003 Mar;21(1):47-51
pubmed: 12718461
Pediatrics. 2013 Apr;131(4):e1071-81
pubmed: 23478860
Fam Pract. 2021 Jul 28;38(4):373-380
pubmed: 33783497
Implement Sci. 2014 Jan 17;9:14
pubmed: 24438584
Eur J Clin Pharmacol. 2006 Feb;62(2):135-42
pubmed: 16389536
Fam Pract. 1999 Oct;16(5):495-500
pubmed: 10533946
West J Med. 1982 Nov;137(5):448-50
pubmed: 6891147
Lancet. 2016 Apr 23;387(10029):1743-52
pubmed: 26898856
Implement Sci. 2014 Oct 11;9:133
pubmed: 25304255
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000259
pubmed: 22696318
Acad Med. 2009 Sep;84(9):1217-25
pubmed: 19707060
BMJ. 2016 Aug 18;354:i4079
pubmed: 27540041
J Eval Clin Pract. 2009 Oct;15(5):807-12
pubmed: 19811593
PLoS Med. 2016 Aug 30;13(8):e1002115
pubmed: 27575599